Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process.

Dipharma Receives the 2nd GMP Certification from Brazilian ANVISA MILAN, Italy, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...

Dipharma expands its Italian R&D Center to increase its analytical services The Company strengthens its analytical R&D capabilities,to better support its customers operating in the CDMO and Generics market. MILAN, Italy, April 04, 2023 (GLOBE NEWSWIRE) -- Dipharma...

Dipharma completes second phase of CGMP expansion at its Kalamazoo site MILAN, Italy, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a global CDMO and leading manufacturer of Active Pharmaceutical Ingredients and advanced Intermediates, announced...

Dipharma receives GMP certification from Brazilian ANVISA MILAN, Italy, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...